EBI Announces Exceptional Speaker Line-Up for IN³ Medical Device 360° Orlando, Feb. 29-Mar. 2

Feb. 15, 2012 - PRLog -- Bridgewater, NJ - Elsevier Business Intelligence (EBI), publisher of “The Gray Sheet” and the medical technology industry's leading provider of strategic partnership and investment conferences, announces an exceptional program and line-up of speakers for its upcoming Investment in Innovation (IN³) Medical Device 360° Conference, being held February 29 - March 2, 2012 at the Ritz-Carlton Orlando, Grande Lakes luxury resort in Orlando, Florida.  IN³ Medical Device 360° Orlando, which features a comprehensive program refreshed for 2012 to benefit all players in the medical device space, will feature presentations by more than 25 innovative early-, mid- and late-stage start-up device companies seeking funding and/or strategic partnership.  The two-day event will also include an outstanding roster of interactive investor panels, venture capital/business development meet-and-greets and networking sessions with industry thought leaders analyzing the most pressing issues facing the global device industry in 2012 and beyond.  

Start-ups presenting in Orlando are developing forward-thinking technologies addressing the following diagnostic and therapeutic device markets, among many others:  asthma, bioabsorbable implants,  cancer, diabetes, glaucoma, imaging, molecular diagnostics, nanotechnology, neurology, neurostimulation, organ transplantation, pain management, polymers, spinal, total joint replacement and urology.  Presenters confirmed to date include Alfa Thermodiagnostics, Inc., Axial Biotech Inc., Brainsway, Cerebid Technologies LLC, Consensus Orthopedics, Cortical Dynamics Ltd., Diabetes Sentry Products, Inc., Encapsule Medical Devices LLC, Enox BioPharma Inc., Health-Chem Diagnostics, Implandata Ophthalmic Products GmbH, Juneau Biosciences, Magneceutical Health, Nano Interface Technology Inc., NinePoint Medical Inc., PCAsso Diagnostics LLC, Peytant Solutions, Inc., Poiesis Medical LLC, Sensimed AG, Smart Perfusion LLC, SpiroSure Inc., StandUp Traction Systems, Inc., Surgical Innovations LLC and Vantix Ltd., among others being added to the program regularly.  

Interactive and timely sessions taking place at IN³ Medical Device 360° Orlando include a pre-conference workshop, "Reimbursement Basics: What You Need to Know to Answer Investor Questions," hosted by Kelli Hallas, Executive Vice President of Reimbursement, Emerson Consultants; a Corporate Buy-Side Perspective Panel moderated by David Cassak, VP of Content, EBI, and Steve Levin, Editor-in-Chief, EBI, "What are Buyers Looking for in 2012"; a medical device innovator panel entitled "Angels, Grants and Venture Debt: Alternative Financing Strategies for Those Seeking Funding in Today's Difficult Marketplace"; a VC panel discussion also hosted by David Cassak and Steve Levin entitled "Making the Pitch: What Do Dealmakers Want?"; and a clinical trials panel, "FDA Hot Topics: Clinical Trials and Risk/Benefit Analysis," featuring William Maisel, Deputy Center Director for Science and Chief Scientist at the CDRH/FDA.  Continuously updated event details are posted at www.in3orlando.com.  

Senior-level investment and business development executives speaking or participating on panels in Orlando include Gary Brothers, Sr. Corporate Development Director, Medtronic, Inc.; Dennis Crowley, VP,  Corporate Development, Covidien; William Marshall, VP, Strategy & Business Development, BD Medical; Peter Shagory, Partner, Baird Venture Partners; Aftab R. Kherani, Principal, Aisling Capital; Thomas Weldon, Managing Partner and Founder, Accuitive Medical Ventures; Scott Weiner, Transactional Partner, Pappas Ventures; Gerry Brunk, Managing Director, Lumira Capital; Mike Bunker, Managing Director, Early Stage Partners; Anya Schiess, Principal, Thomas McNerney & Partners; Ken Massey, Managing Director, LifeLine Ventures; and Don Urbanowicz, Principal, Urbanowicz Consulting, among many others.  

If your emerging company would like to apply to present in Orlando, please contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com.  Partnering software is available and active for all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.  

IN³ Medical Device 360° Orlando will be held at the Ritz-Carlton Orlando, Grande Lakes luxury resort, located on a picturesque 18-hole Greg Norman Signature Golf Course, that also features a 40,000-square-foot spa facility, along with many other amenities.  Event co-sponsors include Medmarc and Biomedic-Insure, Alandra Medical, clinicalprojects international GmbH (CPI), Life Science Intelligence, Mass Medical Angels, Scisive Consulting LP, Emerson Consultants, Inc., FreeMind, and Ronald Trahan Associates.  Visit www.in3orlando.com for full conference and registration details.  EBI will be hosting three additional IN3 Medical Device 360° events in 2012, in London (April 25-26), Boston (June 27-29)  and San Francisco (October 15-17); visit www.elsevierbi.com/conferences for more information.  

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI) is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis.  EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, NJ; Norwalk, CT; Rockville, MD; and Irvine, CA.

CONTACT:
Kayleen Kell
Associate Account Manager
Phone: 1-949-797-7142
1-855-202-5939 toll-free in the USA
Email: k.kell@elsevier.com
Web: www.in3orlando.com

# # #

Elsevier Business Intelligence (EBI) is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry.